Molgenie
Curated by SignalDeveloper of AI-based drug discovery platform
Overview
Molgenie develops an AI-based drug discovery platform. The product EDEN is a scalable computational platform for drug discovery. It predicts the binding of molecules to all drug targets. This is then used to predict the activity of existing compounds and to design new compounds.
Key facts
- Founded
- 2019
- Headquarters
- Stuttgart, Germany
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 4 products and services
- Sign up to view
- Commercial model
- Sign up to view
Contact
- Sign up to view
- Phone
- Sign up to view